Research location
Harrogate
North Yorkshire, United Kingdom
Advertisement
Research activity in Harrogate
North Yorkshire, United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 8 trials and 8 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Harrogate
8 linked trials · page 1 of 1A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose WeightNCT05394519 · 2023-02-01 · 1 site observation
COMPLETED
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 DiabetesNCT03811561 · 2019-05-08 · 1 site observation
ACTIVE_NOT_RECRUITING
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or ObesityNCT03574597 · 2018-10-24 · 1 site observation
COMPLETED
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes MellitusNCT03428945 · 2018-08-15 · 1 site observation
TERMINATED
The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) TrialNCT01616784 · 2011-11-01 · 1 site observation
COMPLETED
Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid ArthritisNCT00913458 · 2009-09-01 · 1 site observation
COMPLETED
Trial of Perioperative Endocrine Therapy - Individualising CareNCT02338310 · 2008-09-01 · 1 site observation
ACTIVE_NOT_RECRUITING
CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV EventsNCT00327418 · 1997-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.